Stempoint Capital Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Stempoint Capital Lp disclosed 60 stock positions valued at approximately $577.91M as of quarter-end June 30, 2026. The largest holdings include TANGO THERAPEUTICS INC, ABIVAX SA, and REVOLUTION MEDICINES INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 60
- Portfolio Value
- $577.91M
Holdings by Sector
Stempoint Capital Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 6.62% | 1,223,019 | +1,022,100 | +508.71% | $38,231,574 |
| ABIVAX SA | ABVX | Healthcare | 6.54% | 283,657 | -30,134 | -9.60% | $37,800,132 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 5.18% | 159,943 | -121,689 | -43.21% | $29,954,125 |
| ERASCA INC | ERAS | Healthcare | 4.96% | 1,565,913 | +1,326,052 | +552.84% | $28,687,526 |
| TYRA BIOSCIENCES INC | TYRA | Healthcare | 3.50% | 632,754 | +439,577 | +227.55% | $20,210,163 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 3.39% | 200,851 | +115,349 | +134.91% | $19,578,955 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 3.05% | 346,914 | -16,524 | -4.55% | $17,605,886 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 2.81% | 602,686 | +69,308 | +12.99% | $16,260,468 |
| SURROZEN INC | SRZN | Healthcare | 2.39% | 602,798 | +406,817 | +207.58% | $13,786,568 |
| KINIKSA PHARMACEUTICALS INTL | KNSA | Other | 2.32% | 209,234 | +209,234 | +100.00% | $13,380,514 |
| SCHOLAR ROCK HLDG CORP | SRRK | Healthcare | 2.28% | 239,146 | -796,350 | -76.91% | $13,153,030 |
| ALKERMES PLC | ALKS | Healthcare | 2.25% | 248,015 | +167,523 | +208.12% | $12,994,746 |
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 2.16% | 37,243 | -19,024 | -33.81% | $12,468,584 |
| ROIVANT SCIENCES LTD | ROIV | Healthcare | 2.13% | 348,408 | -37,392 | -9.69% | $12,330,159 |
| CG ONCOLOGY INC | CGON | Healthcare | 1.96% | 159,349 | -46,273 | -22.50% | $11,321,746 |
| IMMUNOVANT INC | IMVT | Healthcare | 1.84% | 276,527 | -469,967 | -62.96% | $10,654,585 |
| CELCUITY INC | CELC | Healthcare | 1.78% | 98,203 | +38,141 | +63.50% | $10,273,998 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 1.75% | 1,460,093 | +862,684 | +144.40% | $10,103,844 |
| CLIMB BIO INC | ELYM | Other | 1.68% | 742,745 | +742,745 | +100.00% | $9,685,395 |
| SPYRE THERAPEUTICS INC | SYRE | Healthcare | 1.64% | 106,926 | -60,680 | -36.20% | $9,492,890 |
| ZURA BIO LTD | ZURA | Other | 1.40% | 1,368,215 | +614,695 | +81.58% | $8,072,469 |
| INFLARX NV | IFRX | Other | 1.25% | 3,228,255 | +3,228,255 | +100.00% | $7,231,291 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 1.19% | 384,304 | -285,381 | -42.61% | $6,902,100 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 1.15% | 178,412 | -75,855 | -29.83% | $6,638,711 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 1.13% | 2,417,283 | +2,417,283 | +100.00% | $6,502,491 |
| EQUILLIUM INC | EQ | Healthcare | 1.12% | 2,016,607 | +2,016,607 | +100.00% | $6,453,142 |
| DEFINIUM THERAPEUTICS INC | DFTX | Other | 1.12% | 137,124 | -188,359 | -57.87% | $6,450,313 |
| CYTOKINETICS INC | CYTK | Healthcare | 1.11% | 75,603 | -53,974 | -41.65% | $6,440,620 |
| CENTURY THERAPEUTICS INC | IPSC | Healthcare | 0.91% | 2,146,182 | +2,146,182 | +100.00% | $5,258,146 |
| AURA BIOSCIENCES INC | AURA | Healthcare | 0.88% | 714,280 | +714,280 | +100.00% | $5,071,388 |
Showing 30 of 60 holdings in the latest reporting period.
Stempoint Capital Lp Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | PSNL | Personalis, Inc. | CALL | 470,000 | $810,750 |
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 250,000 | $400,000 |
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | CALL | 400,000 | $178,000 |
| Q2 2026 | TNGX | Tango Therapeutics, Inc. | CALL | 100,000 | $175,000 |
| Q2 2026 | RVMD | Revolution Medicines, Inc. | PUT | 30,000 | $127,500 |
| Q2 2026 | ERAS | Erasca, Inc. | PUT | 200,000 | $90,000 |
| Q2 2026 | ARKG | ARK Genomic Revolution ETF | PUT | 100,000 | $75,000 |
| Q2 2026 | ROIV | Roivant Sciences | PUT | 100,000 | $40,000 |
| Q2 2026 | AMGN | Amgen Inc. | PUT | 15,000 | $15,000 |
Showing 9 of 9 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.